Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep 5;104(17):1335-42.
doi: 10.1093/jnci/djs299. Epub 2012 Jul 25.

Temporal trends in cause of death among Swedish and US men with prostate cancer

Affiliations

Temporal trends in cause of death among Swedish and US men with prostate cancer

Mara M Epstein et al. J Natl Cancer Inst. .

Abstract

Background: A growing proportion of men diagnosed with localized prostate cancer detected through prostate-specific antigen testing are dying from causes other than prostate cancer. Temporal trends in specific causes of death among prostate cancer patients have not been well described.

Methods: We analyzed causes of death among all incident prostate cancer cases recorded in the nationwide Swedish Cancer Registry (1961-2008; n = 210 112) and in the US Surveillance, Epidemiology, and End Results Program (1973-2008; n = 490 341). We calculated the cumulative incidence of death due to seven selected causes that accounted for more than 80% of the reported deaths (including ischemic heart disease and non-prostate cancer) and analyzed mortality trends by calendar year and age at diagnosis and length of follow-up.

Results: During follow-up through 2008, prostate cancer accounted for 52% of all reported deaths in Sweden and 30% of reported deaths in the United States among men with prostate cancer; however, only 35% of Swedish men and 16% of US men diagnosed with prostate cancer died from this disease. In both populations, the cumulative incidence of prostate cancer-specific death declined during follow-up, while the cumulative incidences of death from ischemic heart disease and non-prostate cancer remained constant. The 5-year cumulative incidence of death from prostate cancer among all men was 29% in Sweden and 11% in the United States.

Conclusions: In Sweden and the United States, men diagnosed with prostate cancer are less likely to die from prostate cancer than from another cause. Because many of these other causes of death are preventable through changes in lifestyle, interventions that target lifestyle factors should be integrated into prostate cancer management.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The distribution of cause-specific cumulative incidence of death among Swedish men with prostate cancer by age and year of diagnosis, 1961–2008. *Risk of cause-specific death, does not account for competing risks. Cancer other than prostate cancer; Other causes, including diabetes mellitus, external causes (including trauma and suicide), chronic obstructive pulmonary disease, and all other specified causes.
Figure 2.
Figure 2.
The distribution of cause-specific cumulative incidence of death among US men with prostate cancer by year of diagnosis, 1973–2008. *Risk of cause-specific death, does not account for competing risks. Cancer other than prostate cancer; Other causes, including diabetes mellitus, external causes (including trauma and suicide), chronic obstructive pulmonary disease, and all other specified causes.

Comment in

References

    1. Meyer MS, Mucci LA, Andersson SO, et al. Homogeneous prostate cancer mortality in the Nordic countries over four decades. Eur Urol. 2010;58(3):427 432. - PMC - PubMed
    1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69 90 - PubMed
    1. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981 990 - PubMed
    1. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst. 2009;101(19):1325 1329 - PMC - PubMed
    1. Lu-Yao GL, Albertsen PC, Moore DF, et al. Outcomes of localized prostate cancer following conservative management. JAMA. 2009;302(11): 1202 1209 - PMC - PubMed

Publication types

Substances